The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Overdose
Risk Behavior
Interventions
BEHAVIORAL:
Co-Dispensing
Sponsor
Kaiser Permanente
Collaborators
[object Object]
[object Object]